# HIV

## HIV Clinical Staging Classifications

### WHO Clinical Stage (used in low- and middle-income countries)

#### Stage 1

- Asymptomatic
- Persistent generalised lymphadenopathy

#### Stage 2

- Unexplained moderate weight loss (< 10% of body weight)
- Recurrent upper respiratory tract infections
- Herpes zoster
- Angular cheilitis
- Recurrent oral ulceration
- Rapular pruritic eruptions
- Seborrhoeic dermatitis
- Fungal nail infections

#### Stage 3

- Unexplained severe weight loss (> 10% of body weight)
- Unexplained chronic diarrhoea for > 1 month
- Unexplained persistent fever (> 37.5Â°C for > 1 month)
- Unexplained anaemia (< 80 g/L), neutropenia (< 0.5x10e9/L) and/or chronic thrombocytopenia (< 50x10e9/L)
- Persistent oral candidiasis
- Oral hairy leucoplakia
- Pulmonary tuberculosis
- Severe bacterial infections
- Acute necrotising ulceration stomatitis, gingivitis or periodontitis

#### Stage 4

1. Bacterial Infections
   - Recurrent bacterial pneumonia
   - Tuberculosis (Extrapulmonary)
   - Non-tuberculous Mycobacterial infection (Disseminated/Extrapulmonary)
   - Sepsis (Recurrent)
1. Viral Infections
   - Cytomegalovirus (CMV) disease (Outside liver, spleen, nodes)
   - Herpes simplex (Chronic >1 month, ulcers or visceral involvement)
   - Progressive multifocal leukoencephalopathy (PML)
1. Fungal Infections
   - Candidiasis (Esophagus, Trachea, Bronchi, Lungs)
   - Cryptococcosis (Extrapulmonary)
   - Disseminated endemic mycosis (Histoplasmosis, Coccidioidomycosis, etc.)
1. Protozoal & Parasitic Infections
   - Toxoplasmosis (Cerebral)
   - Cryptosporidiosis (Chronic >1 month)
   - Cystoisosporiasis (Chronic >1 month)
   - Leishmaniasis (Atypical, Disseminated)
1. Malignancies
   - Kaposi's sarcoma
   - Cervical carcinoma (Invasive)
   - Lymphoma (B-cell Non-Hodgkin or Cerebral lymphoma)
1. Systemic Involvement
   - HIV Wasting Syndrome
   - HIV encephalopathy
   - HIV-associated Nephropathy (Symptomatic)
   - HIV-associated Cardiomyopathy (Symptomatic)
   - HIV-associated Systemic Opportunistic Infections

## Treatment of Common Opportunistic Infections in Adults with AIDS

> Primary prophylaxis is used to prevent opportunistic infections that have not yet occured.

> Secondary prophylaxis is used to prevent recurrece of opportunistic infections because many may recur after an intial response to therapy.<br/>Secondary prophylaxis can be discontinued when CD4 counts > 200 cells/mm3.

| Opportunistic infection                    | Treatment                                                                                    | Alternative Treatment                                                               | Secondary Prophylaxis                 |
| :----------------------------------------- | :------------------------------------------------------------------------------------------- | :---------------------------------------------------------------------------------- | :------------------------------------ |
| _Pneumocystis jirovecii_ Pneumonia         | `Co-trimoxazole` for 21 days; Early adjunctive `prednisone` if hypoxic                       | `Clindamycin` + `Primaquine` for 21 days                                            | `Co-trimoxazole` daily                |
| Cerebral Toxoplasmosis                     | `Sulfadiazine` + `Pyrimethamine` + `Folic acid` for 6 weeks                                  | `Co-trimoxazole` for 3 months                                                       | `Co-trimoxazole` daily                |
| _Cystoisospora belli_ Diarrhoea            | `Co-trimoxazole` for 10 days                                                                 | `Ciprofloxacin` for 10 days                                                         | `Co-trimoxazole` daily                |
| Cryptococcosis                             | Liposomal `amphotericin B` + `Flucytosine` for 7 days, followed by `Fluconazole` for 8 weeks | `Amphotericin B` + `Fluconazole` for 2 weeks, followed by `Fluconazole` for 8 weeks | `Fluconazole` daily                   |
| Oesophageal Candidiasis                    | `Fluconazole` for 2 weeks                                                                    | `Itraconazole` for 14-21 days                                                       | Not usually recommended               |
| Disseminated _Mycobacterium avium_ Complex | `Clarithromycin` + `Ethambutol` daily                                                        | `Azithromycin` + `Ethambutol` daily                                                 | Continue treatment for minimal 1 year |
| Herpes Simplex Ulcers                      | `Aciclovir` for 5-10 days                                                                    | `Valaciclovir` or Famciclovir for 5-10 days                                         | `Aciclovir` daily                     |

<details>
<summary>Opportunistics infections reduced by co-trimoxazole</summary>

1. _Pneumocystis jirovecii_ pneumonia
1. Bacterial pneumonia
1. Bacteraemia
1. Cerebral Toxoplasmosis
1. Cystoisosporiasis
1. Malaria

</details>

## Immunisation

> Vaccination with live organisms is contraindicated in patients with severe immune suppression!!!

> BCG (Bacille Calmette-Guerin) is contraindicated in PLWH (Patients living with HIV)!!!

### Recommended vaccines

1. Hepatitis A
1. Human papillomavirus (HPV)
1. Measles, mumps and rubella (MMR)
1. Meningococcus
1. Diphtheria/pertussis/tetanus (DPT)
1. Inactivated poliovirus vaccine (IPV)
1. Checkenpox

## Anti-Retroviral Therapy (ART)

| Classes                                                  | Drugs                                                     |
| :------------------------------------------------------- | :-------------------------------------------------------- |
| Nucleoside reverse transcriptase inhibitors (NRTIs)      | `Abacavir`, `Emtricitabine`, `Lamivudine`, `Tenofovir`    |
| Non-nucleoside reverse transcriptase inhibitors (NNRTIs) | `Efavirenz`, `Rilpivirine` (only if viral load < 100,000) |
| Protease inhibitors (PIs)                                | `Atazanavir`, `Darunavir`, `Lopinavir`                    |
| Integrase Strand Transfer Inhibitors (INSTIs)            | `Dolutegravir`, `Bictegravir`                             |

### Highly Active Anti-Retroviral Therapy (HAART)

1. Two NRTIs + One NNRTI
1. Two NRTIs + One PI (boosted with `Ritonavir` or `Cobicistat`)
1. Two NRTIs + One INSTI

### Immune Reconstitution Inflammatory Syndrome (IRIS)

> A common early complication of ART, especially in patients who start ART with CD4 counts below 50 cells/mm3.

- Can be mild or life-threatening
- Types:
  - **Paradoxical IRIS**: A previously diagnosed infection worsens after starting ART
  - **Unmasking IRIS**: A previously undiagnosed infection appears after starting ART
- Management:
  - Continue ART
  - Ensure the infection is adequately treated
